Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
4.450
-0.200 (-4.30%)
At close: Sep 18, 2026, 4:00 PM EDT
4.530
+0.080 (1.80%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $76.45 million as of September 18, 2026. Its market cap has increased by 83.32% in one year.
Market Cap
76.45M
Enterprise Value
67.06M
1-Year Change
83.32%
Ranking
Category
Stock Price
$4.45
ChartMarket Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.60M to $76.45M, a decrease of -82.49%. That is a compound annual growth rate of -19.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 76.40M | -3.17% |
| Dec 31, 2025 | 78.90M | 147.34% |
| Dec 31, 2024 | 31.90M | -89.64% |
| Dec 29, 2023 | 307.90M | 172.48% |
| Dec 30, 2022 | 113.00M | -55.18% |
| Dec 31, 2021 | 252.10M | -15.32% |
| Dec 31, 2020 | 297.70M | -27.32% |
| Dec 31, 2019 | 409.60M | 95.61% |
| Dec 31, 2018 | 209.40M | -52.04% |
| Jun 15, 2018 | 436.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 81.64M |
| NeOnc Technologies Holdings | 81.03M |
| Connect Biopharma Holdings | 80.61M |
| MAIA Biotechnology | 79.68M |
| Acrivon Therapeutics | 79.28M |
| Gain Therapeutics | 76.81M |
| RenovoRx | 76.27M |
| Cingulate | 76.20M |